A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability

References

• Agirre M, Zarate J, Puras G, Ojeda E, Pedraz JL. 2015. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification. Drug Deliv. 22(1):100–110.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. 2016. Nanoparticles in the clinic. Bioeng Transl Med. 1(1):10–29.
   PubMed Web of Science ®Google Scholar
• Bahari LAS, Hamishehkar H. 2016. The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; A comparative literature review. Adv Pharm Bull. 6(2):143–151.
   PubMed Web of Science ®Google Scholar
• Balguri SP, Adelli GR, Majumdar S. 2016. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm. 109:224–235.
   PubMed Web of Science ®Google Scholar
• Barakat NS. 2010. Self-emulsifying system for improving drug dissolution and bioavailability: in vitro/in vivo evaluation. Drug Dev Res. 71:149–158.
   Web of Science ®Google Scholar
• Barichello JM, Ishida T, Kiwada H. 2010. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation. In: Weissig V, editor. Liposomes, methods in molecular biology. Clifton (NJ): Humana Press. Vol. 605; p. 461–472.
   Google Scholar
• Bishop CJ, Kozielski KL, Green JJ. 2015. Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles. J Control Release. 219:488–499.
   PubMed Web of Science ®Google Scholar
• Blane A, Fanucchi S. 2015. Effect of pH on the structure and DNA binding of the FOXP2 forkhead domain. Biochemistry. 54(25):4001–4007.
   PubMed Web of Science ®Google Scholar
• Bose RJC, Arai Y, Ahn JC, Park H, Lee SH. 2015. Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery. Int J Nanomedicine. 10:5367–5382.
   PubMed Web of Science ®Google Scholar
• Chou T-C, Martin N. 2005. CompuSyn for drug combinations: PC software and user’s guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values. New Jersey: ComboSyn Inc.; [accessed 2019 Oct 10]. http://www.combosyn.com/index.html.
   Google Scholar
• Das S, Chaudhury A. 2011. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 12(1):62–76.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan R. 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 47(1):139–151.
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. 2019. Single-step and low-energy method to prepare solid lipid nanoparticles and nanostructured lipid carriers using biocompatible solvents. Eur J Pharm Res. 1(1):12–19.
   Google Scholar
• Di Ianni ME, Islan GA, Chain CY, Castro GR, Talevi A, Vela ME. 2017. Interaction of solid lipid nanoparticles and specific proteins of the corona studied by surface plasmon resonance. J Nanomater. 2017:1–11.
   Web of Science ®Google Scholar
• Doktorovova S, Shegokar R, Rakovsky E, Gonzalez-Mira E, Lopes CM, Silva AM, Martins-Lopes P, Muller RH, Souto EB. 2011. Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies. Int J Pharm. 420(2):341–349.
   PubMedGoogle Scholar
• Doktorovova S, Souto EB, Silva AM. 2014. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. Eur J Pharm Biopharm. 87(1):1–18.
   PubMed Web of Science ®Google Scholar
• Dong X, Mattingly CA, Tseng M, Cho M, Adams VR, Mumper RJ. 2009. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur J Pharm Biopharm. 72(1):9–17.
   PubMed Web of Science ®Google Scholar
• Fang Y-P, Lin Y-K, Su Y-H, Fang J-Y. 2011. Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. Chem Pharm Bull. 59(2):266–271.
   PubMed Web of Science ®Google Scholar
• Gasco MR, inventor; Method for producing solid lipid microspheres having a narrow size distribution. 1993 Oct 5. United States patent US 52,502,36A. https://patents.google.com/patent/US5250236A/en.
   Google Scholar
• Gupta B, Yong CS, Kim JO. 2017. Solid matrix-based lipid nanoplatforms as carriers for combinational therapeutics in cancer. J Pharm Investig. 47(6):461–473.
   Google Scholar
• Hagerman PJ. 1997. Flexibility of RNA. Annu Rev Biophys Biomol Struct. 26(1):139–156.
   PubMedGoogle Scholar
• Honary S, Zahir F. 2013. Effect of zeta potential on the properties of nano-drug delivery systems - a review (Part 2). Trop J Pharm Res. 12:265–273.
   Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, Bao G. 2016. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 11(6):673–692.
   PubMed Web of Science ®Google Scholar
• Huang S, Sinicrope FA. 2010. Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Mol Cancer Ther. 9(3):742–750.
   PubMed Web of Science ®Google Scholar
• ISO/EN10993-5. 2009. International Organization for Standardization 10993-5 Biological evaluation of medical devices - Part 5: tests for in vitro cytotoxicity methods. 3 ed. Geneva, Switzerland: International Organization for Standardization (ISO).
   Google Scholar
• Jiang S, Eltoukhy AA, Love KT, Langer R, Anderson DG. 2013. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett. 13(3):1059–1064.
   PubMed Web of Science ®Google Scholar
• Kelidari HR, Saeedi M, Akbari J, Morteza-Semnani K, Valizadeh H, Maniruzzaman M, Farmoudeh A, Nokhodchi A. 2017. Development and optimisation of spironolactone nanoparticles for enhanced dissolution rates and stability. AAPS PharmSciTech. 18(5):1469–1474.
   PubMed Web of Science ®Google Scholar
• Khalil RM, Abd-Elbary A, Kassem MA, Ghorab MM, Basha M. 2014. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam. Pharm Dev Technol. 19(3):304–314.
   PubMed Web of Science ®Google Scholar
• Khosa A, Reddi S, Saha RN. 2018. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. 103:598–613.
   PubMed Web of Science ®Google Scholar
• Kim TW, Kim YJ, Chung H, Kwon IC, Sung HC, Jeong SY. 2002. The role of non-ionic surfactants on cationic lipid mediated gene transfer. J Control Release. 82(2–3):455–465.
   PubMed Web of Science ®Google Scholar
• Kotmakçı M, Akbaba H, Erel G, Ertan G, Kantarcı G. 2017. Improved method for solid lipid nanoparticle preparation based on hot microemulsions: preparation, characterization, cytotoxicity, and hemocompatibility evaluation. AAPS PharmSciTech. 18(4):1355–1365.
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. 2011. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm. 406(1–2):163–172.
   PubMedGoogle Scholar
• Kwok A, McCarthy D, Hart SL, Tagalakis AD. 2016. Systematic comparisons of formulations of linear oligolysine peptides with siRNA and plasmid DNA. Chem Biol Drug Des. 87(5):747–763.
   PubMed Web of Science ®Google Scholar
• Lee DW, Marasini N, Poudel BK, Kim JH, Cho HJ, Moon BK, Choi HG, Yong CS, Kim JO. 2014. Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS). J Microencapsul. 31(1):31–40.
   PubMed Web of Science ®Google Scholar
• Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M. 2005. Lipid nanoparticles for skin penetration enhancement - Correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release. 110(1):151–163.
   PubMed Web of Science ®Google Scholar
• Lundy DJ, Chen KH, Toh EKW, Hsieh P. 2016. Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury. Sci Rep. 6(1):1–10.
   PubMedGoogle Scholar
• Mehnert W, Mader K. 2001. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev. 47(2–3):165–196.
   PubMed Web of Science ®Google Scholar
• Minaeva OV, Brodovskaya EP, Pyataev MA, Gerasimov MV, Zharkov MN, Yurlov IA, Kulikov OA, Kotlyarov AA, Balykova LA, Kokorev AV, et al. 2017. Comparative study of cytotoxicity of ferromagnetic nanoparticles and magnetitecontaining polyelectrolyte microcapsules. J Phys: Conf Ser. 784:012038.
   Google Scholar
• Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Muller RH, Shegokar RM, Keck C. 2011. 20 Years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. CDDT. 8(3):207–227.
   Google Scholar
• Naseri N, Valizadeh H, Zakeri-Milani P. 2015. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull. 5(3):305–313.
   PubMed Web of Science ®Google Scholar
• Park K. 2014. Controlled drug delivery systems: past forward and future back. J Control Release. 190:3–8.
   PubMed Web of Science ®Google Scholar
• Pathak P, Nagarsenker M. 2009. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech. 10(3):985–992.
   PubMed Web of Science ®Google Scholar
• Paull KD, Shoemaker RH, Boyd MR, Parsons JL, Risbood PA, Barbera WA, Sharma MN, Baker DC, Hand E, Scudiero DA, et al. 1988. The synthesis of XTT: a new tetrazolium reagent that is bioreducible to a water-soluble formazan. J. Heterocyclic Chem. 25(3):911–914.
   Web of Science ®Google Scholar
• Ruktanonchai U, Bejrapha P, Sakulkhu U, Opanasopit P, Bunyapraphatsara N, Junyaprasert V, Puttipipatkhachorn S. 2009. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. AAPS PharmSciTech. 10(1):227–234.
   PubMed Web of Science ®Google Scholar
• Salimi A, Sharif Makhmal Zadeh B, Hemati AA, Akbari Birgani S. 2014. Design and evaluation of self-emulsifying drug delivery system (SEDDS) Of carvedilol to improve the oral absorption. Jundishapur J Nat Pharm Prod. 9(3):9.
   PubMedGoogle Scholar
• Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML. 2017. Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye – Part II - Ocular drug-loaded lipid nanoparticles. Eur J Pharm Biopharm. 110:58–69.
   PubMed Web of Science ®Google Scholar
• Shah R, Eldridge D, Palombo E, Harding I. 2015. Lipid nanoparticles: production, characterization and stability. Cham: Springer. (SpringerBriefs in Pharmaceutical Science & Drug Development; p. 1–9.
   Google Scholar
• Shidhaye S, Vaidya R, Sutar S, Patwardhan A, Kadam V. 2008. Solid lipid nanoparticles and nanostructured lipid carriers – innovative generations of solid lipid carriers. CDD. 5(4):324–331.
   PubMedGoogle Scholar
• Składanowski M, Golinska P, Rudnicka K, Dahm H, Rai M. 2016. Evaluation of cytotoxicity, immune compatibility and antibacterial activity of biogenic silver nanoparticles. Med Microbiol Immunol. 205(6):603–613.
   PubMed Web of Science ®Google Scholar
• Song A, Zhang X, Li Y, Mao X, Han F. 2016. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Drug Dev Ind Pharm. 42(8):1308–1314.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. 2004a. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278(1):71–77.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. 2004b. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm. 58(1):83–90.
   PubMed Web of Science ®Google Scholar
• Tabatt K, Sameti M, Olbrich C, Müller RH, Lehr CM. 2004. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. Eur J Pharm Biopharm. 57(2):155–162.
   PubMed Web of Science ®Google Scholar
• Teixeira MC, Carbone C, Souto EB. 2017. Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery. Prog Lipid Res. 68:1–11.
   PubMed Web of Science ®Google Scholar
• Tosta FV, Andrade LM, Mendes LP, Anjos JV, Alonso A, Marreto RN, Lima EM, Taveira SF. 2014. Paclitaxel-loaded lipid nanoparticles for topical application: the influence of oil content on lipid dynamic behavior, stability, and drug skin penetration. J Nanoparticle Res. 16:1–12.
   Web of Science ®Google Scholar
• Vighi E, Ruozi B, Montanari M, Battini R, Leo E. 2007. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm. 67(2):320–328.
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhang S, Tang M, Zhang T, Wang Y, Hieda Y, Takeshita H. 2012. Comparative study on toxic effects induced by oral or intravascular administration of commonly used disinfectants and surfactants in rats. J Appl Toxicol. 32(7):480–487.
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. 2014. Non-viral vectors for gene-based therapy. Nat Rev Genet. 15(8):541–555.
   PubMed Web of Science ®Google Scholar
• Yu YH, Kim E, Park DE, Shim G, Lee S, Kim YB, Kim CW, Oh YK. 2012. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Eur J Pharm Biopharm. 80(2):268–273.
   PubMed Web of Science ®Google Scholar
• Zhi D, Zhang S, Wang B, Zhao Y, Yang B, Yu S. 2010. Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery. Bioconjugate Chem. 21(4):563–577.
   PubMed Web of Science ®Google Scholar